These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 4310020)

  • 1. Comparative study of the effect of three antibiotics on renal function.
    Caldwell AD; Martin AJ; Trigger DJ
    Br J Pharmacol; 1969 Sep; 37(1):283-93. PubMed ID: 4310020
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacologic and toxicologic studies with the polymyxins. II. Comparative pharmnacologic studies of the sulfate and methanesulfonate salts of polymyxin B and colistin in dogs.
    al-Khayyat AA; Aronson AL
    Chemotherapy; 1973; 19(2):82-97. PubMed ID: 4357724
    [No Abstract]   [Full Text] [Related]  

  • 3. Polymyxin B, colistin, and sodium colistimethate.
    Horton J; Pankey GA
    Med Clin North Am; 1982 Jan; 66(1):135-42. PubMed ID: 6278236
    [No Abstract]   [Full Text] [Related]  

  • 4. Effects of large doses of colistin sulphomethate sodium on renal function.
    Price DJ; Graham DI
    Br Med J; 1970 Nov; 4(5734):525-7. PubMed ID: 5483321
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The activity of polymyxins against dense populations of Escherichia coli.
    Greenwood D
    J Gen Microbiol; 1975 Nov; 91(1):110-8. PubMed ID: 172601
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Measurement of urinary N-acetyl-b-D-glucosaminidase in adult patients with cystic fibrosis: before, during and after treatment with intravenous antibiotics.
    Etherington C; Bosomworth M; Clifton I; Peckham DG; Conway SP
    J Cyst Fibros; 2007 Jan; 6(1):67-73. PubMed ID: 16844430
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nephrotoxicity of Polymyxins: Is There Any Difference between Colistimethate and Polymyxin B?
    Zavascki AP; Nation RL
    Antimicrob Agents Chemother; 2017 Mar; 61(3):. PubMed ID: 27993859
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intravenous colistin sulphomethate in acute respiratory exacerbations in adult patients with cystic fibrosis.
    Conway SP; Pond MN; Watson A; Etherington C; Robey HL; Goldman MH
    Thorax; 1997 Nov; 52(11):987-93. PubMed ID: 9487348
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The activity of polymyxins against Escherichia coli in an in-vitro model of the urinary bladder.
    Greenwood D; O'Grady F
    J Med Microbiol; 1977 May; 10(2):255-9. PubMed ID: 192891
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Potential Toxicity of Polymyxins in Human Lung Epithelial Cells.
    Ahmed MU; Velkov T; Lin YW; Yun B; Nowell CJ; Zhou F; Zhou QT; Chan K; Azad MAK; Li J
    Antimicrob Agents Chemother; 2017 Jun; 61(6):. PubMed ID: 28416543
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effects of polymyxin B and E (colistin) on blood coagulation, thrombocyte function, and fibrin structure (author's transl)].
    Klingemann HG; Egbring R; Kaffarnik H
    Arzneimittelforschung; 1980; 30(10):1719-21. PubMed ID: 6254544
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Toxicity after prolonged (more than four weeks) administration of intravenous colistin.
    Falagas ME; Rizos M; Bliziotis IA; Rellos K; Kasiakou SK; Michalopoulos A
    BMC Infect Dis; 2005 Jan; 5():1. PubMed ID: 15642116
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Electroencephalographic changes after intravenous administration of antibiotics.
    Doutlík S; Vacek V; Vacek Z
    Arzneimittelforschung; 1967 Sep; 17(9):1177-81. PubMed ID: 4300334
    [No Abstract]   [Full Text] [Related]  

  • 14. Nephrotoxicity in Patients with or without Cystic Fibrosis Treated with Polymyxin B Compared to Colistin.
    Crass RL; Rutter WC; Burgess DR; Martin CA; Burgess DS
    Antimicrob Agents Chemother; 2017 Apr; 61(4):. PubMed ID: 28167560
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sensitivity tests of klebsiella, enterobacter, and serratia.
    Sanford JP
    J Infect Dis; 1969; 119(4):388-90. PubMed ID: 4306974
    [No Abstract]   [Full Text] [Related]  

  • 16. Framework for optimisation of the clinical use of colistin and polymyxin B: the Prato polymyxin consensus.
    Nation RL; Li J; Cars O; Couet W; Dudley MN; Kaye KS; Mouton JW; Paterson DL; Tam VH; Theuretzbacher U; Tsuji BT; Turnidge JD
    Lancet Infect Dis; 2015 Feb; 15(2):225-34. PubMed ID: 25459221
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Mechanisms of action of and resistance to colistinpolymyxin group antibiotics including resistance of colitin-producing bacterium, Bacillus colistinus to colistin (author's transl)].
    Shirai M; Aida T
    Tanpakushitsu Kakusan Koso; 1981 Nov; 26(14):2070-83. PubMed ID: 6276922
    [No Abstract]   [Full Text] [Related]  

  • 18. Studies on the combined action of antibiotics on Pseudomonas aeruginosa strains.
    Muszyński Z; Kedzia W
    Arch Immunol Ther Exp (Warsz); 1973; 21(5):743-51. PubMed ID: 4358926
    [No Abstract]   [Full Text] [Related]  

  • 19. Nephrotoxicity of antibiotics.
    Kunin CM
    JAMA; 1967 Oct; 202(3):204-8. PubMed ID: 4293095
    [No Abstract]   [Full Text] [Related]  

  • 20. [Isolation rate of Pseudomonas aeruginosa from clinical materials and its susceptibility to antibiotics].
    Oguri T; Kosakai N
    Jpn J Antibiot; 1971 Jun; 24(3):121-5. PubMed ID: 4327335
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.